Literature DB >> 16458424

Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production.

Valentine Panel1, Pierre-Yves Boëlle, Jesus Ayala-Sanmartin, Anne-Marie Jouniaux, Richard Hamelin, Joëlle Masliah, Germain Trugnan, Jean-François Fléjou, Dominique Wendum.   

Abstract

Cytoplasmic phospholipase A2 (cPLA2) has a key role in prostaglandin production. The role of cPLA2 in intestinal tumorigenesis has been suggested, however, contradictory data are found in the literature. We evaluated cPLA2 and cyclooxygenase-2 (COX-2) protein expression in 65 colon carcinomas by immunohistochemistry, and in eight colorectal cancer cell lines by Western Blot. PGE2 production was evaluated by enzyme-immunoassay in the cell lines. We demonstrate that cPLA2 is overexpressed in approximately 50% of colon cancers and cell lines. cPLA2 expression is correlated with COX-2 expression. Both cPLA2 and COX-2 expressions are important in regard to PGE2 production. Our data suggest that cPLA2 might be involved in colon tumor development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458424     DOI: 10.1016/j.canlet.2005.11.045

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.

Authors:  Takeshi Ueda; Masato Sasaki; Andrew J Elia; Iok In Christine Chio; Koichi Hamada; Rikiro Fukunaga; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

2.  Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.

Authors:  Francesco Caiazza; Brian J Harvey; Warren Thomas
Journal:  Mol Endocrinol       Date:  2010-03-08

Review 3.  Roles of cPLA2alpha and arachidonic acid in cancer.

Authors:  Masako Nakanishi; Daniel W Rosenberg
Journal:  Biochim Biophys Acta       Date:  2006-09-15

4.  Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue.

Authors:  F Jahns; A Wilhelm; N Jablonowski; H Mothes; Mariya Radeva; A Wölfert; K O Greulich; M Glei
Journal:  Carcinogenesis       Date:  2011-03-31       Impact factor: 4.944

5.  The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.

Authors:  Tuulia Avoranta; Jari Sundström; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen; Jukka Laine
Journal:  Virchows Arch       Date:  2010-10-12       Impact factor: 4.064

6.  Short-period hypoxia increases mouse embryonic stem cell proliferation through cooperation of arachidonic acid and PI3K/Akt signalling pathways.

Authors:  S H Lee; M Y Lee; H J Han
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

7.  Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.

Authors:  Xia Zhang; Qiong Wu; Lu Gan; Guan-Zhen Yu; Rui Wang; Zi-Shu Wang; Jie-Jun Wang; Xi Wang
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

8.  Regulation of arachidonate remodeling enzymes impacts eosinophil survival during allergic asthma.

Authors:  Michael C Seeds; Kristina K Peachman; David L Bowton; Kelly L Sivertson; Floyd H Chilton
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-16       Impact factor: 6.914

Review 9.  Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.

Authors:  Hannah Schneider; Annika Braun; Joachim Füllekrug; Wolfgang Stremmel; Robert Ehehalt
Journal:  Int J Mol Sci       Date:  2010-10-25       Impact factor: 5.923

10.  Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.

Authors:  Sung Chul Lim; Hoon Cho; Tae Bum Lee; Cheol Hee Choi; Young Don Min; Sung Soo Kim; Kyung Jong Kim
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.